Scarica l'app Stockscreener
293.46
0.57%
1.66
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CI Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$291.80
Aprire:
$293.57
Volume 24 ore:
761.53K
Relative Volume:
0.48
Capitalizzazione di mercato:
$77.63B
Reddito:
$278.13B
Utile/perdita netta:
$6.74B
Rapporto P/E:
12.43
EPS:
23.6047
Flusso di cassa netto:
$7.66B
1 W Prestazione:
+1.98%
1M Prestazione:
-0.79%
6M Prestazione:
+5.20%
1 anno Prestazione:
-4.96%
Intervallo 1D:
$289.31
$294.23
Intervallo di 1 settimana:
$275.80
$296.60
Portata 52W:
$239.51
$315.47
Cigna Group Stock (CI) Company Profile
Nome
Cigna Group
Settore
Industria
Telefono
(860) 226-6000
Indirizzo
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
293.46 | 77.63B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
424.62 | 385.62B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.15 | 132.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
416.23 | 90.39B | 200.42B | 5.24B | 6.45B | 23.50 |
HUM
Humana Inc
|
392.22 | 47.09B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-02-06 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2024-02-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-06-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-11-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Downgrade | Jefferies | Buy → Hold |
| 2022-06-22 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Hold |
| 2022-05-27 | Ripresa | Bernstein | Mkt Perform |
| 2022-05-26 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-02-07 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-11-17 | Iniziato | Seaport Research Partners | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-10 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-06 | Reiterato | BofA Securities | Buy |
| 2021-08-06 | Reiterato | Citigroup | Buy |
| 2021-08-06 | Reiterato | Deutsche Bank | Buy |
| 2021-08-06 | Reiterato | Jefferies | Buy |
| 2021-08-06 | Reiterato | Mizuho | Buy |
| 2021-08-06 | Reiterato | Oppenheimer | Outperform |
| 2021-08-06 | Reiterato | Truist | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-04 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Iniziato | Mizuho | Buy |
| 2019-09-30 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-08-06 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Iniziato | UBS | Buy |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-12-24 | Iniziato | Edward Jones | Buy |
| 2018-03-13 | Iniziato | Bernstein | Mkt Perform |
| 2018-03-08 | Iniziato | Barclays | Overweight |
| 2018-01-03 | Iniziato | Goldman | Neutral |
| 2017-11-03 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-06-22 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-06-12 | Iniziato | Credit Suisse | Outperform |
| 2017-06-07 | Iniziato | Morgan Stanley | Overweight |
| 2017-05-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-04-05 | Iniziato | Deutsche Bank | Buy |
Mostra tutto
Cigna Group Borsa (CI) Ultime notizie
Cigna Group stock holds steady on its business mix - ad-hoc-news.de
Built with America: The Cigna Group’s 230-year history of innovation in service of customers - The Cigna Group Newsroom
Cigna Group (NYSE: CI) officer Bryan Holgerson details stock, 401(k) and option positions in Form 3 - Stock Titan
Cigna Group (NYSE: CI) officer Adam Kautzner details stock and option holdings - Stock Titan
Cigna Group (NYSE: CI) officer Jason Sadler reports share and option holdings - Stock Titan
Cigna Group (CI) officer Sanford Paul A reports holding 4,073 common shares - Stock Titan
Cigna Group (NYSE: CI) officer Matthew Perlberg reports initial stock and option holdings - Stock Titan
CI Maintained by Bernstein -- Price Target Raised to $381 - GuruFocus
What to Expect From Cigna's Next Quarterly Earnings Report - Yahoo Finance
Bernstein Adjusts Price Target on Cigna Group to $381 From $371 - marketscreener.com
Bernstein raises Cigna stock price target to $381 on earnings outlook - Investing.com
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
CIGNA (CI) PT Raised to $381 at Bernstein SocGen Group - StreetInsider
Independent Pharmacies Accuse Prime Therapeutics of Price-Fixing Scheme With Express Scripts - Benzinga
Lawmakers Target the Power of Health Insurance Giants - The New York Times
Did Cigna's (CI) US$100 Million AI Pharmacy Bet Just Rewire Its Specialty-Care Narrative? - simplywall.st
Hope House Accepts Cigna, Aetna & UMR for Scottsdale Rehab - The Malone Telegram
Hope House Integrates UMR, Cigna & Aetna Into Admissions - The Malone Telegram
Another Wave Of Double-Digit Obamacare Rate Hikes Coming For 2027 - Forbes
Cigna Group focuses on health benefits growth as investors watch the US managed-care sector - Ad-hoc-news.de
The Cigna Group Foundation Launches 2026 Grant Program to Support Veterans - AOL.com
Cigna’s SWOT analysis: stock navigates PBM transition challenges - Investing.com
Cigna’s SWOT analysis: stock navigates PBM transition challenges By Investing.com - Investing.com Canada
Cigna Group stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Josh Michelson Appointed Executive Vice President, Chief Strategy and Innovation Officer at The Cigna Group - hrtoday.in
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock’s Asembia Buy - Forbes
The Cigna Group sets July 30 earnings call, webcast and replay - Stock Titan
Cigna Group focuses on health benefits and steady operations - ad-hoc-news.de
Cigna Group (CI) Could Be 17% Undervalued On Its $100 Million Evernorth AI Push - simplywall.st
Cigna Group stock underperforms Monday when compared to competitors - MarketWatch
The Cigna Group highlights its health services model as investors track long-term growth potential - ad-hoc-news.de
Prime Therapeutics Accused of Deflating Pharmacy Pay Rates (1) - Bloomberg Law News
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off? - TradingView
Cigna slips as investors weigh PBM transition and a lack of fresh catalysts - Quiver Quantitative
Cigna Group outlines its role in US health coverage and benefits - ad-hoc-news.de
Cigna Group (CI) Stock Analysis: Unpacking an 18% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews
Cigna (CI) Stock Just Lost Its Place In Key Russell Growth Indexes - Yahoo Finance
Cigna (CI) Stock Still Looks Cheap As Earnings Stay Strong - Yahoo Finance
Cigna (CI) Launches AI Pharmacy Program With $100 Million Behind It - simplywall.st
What Cigna Group (CI)'s US$100 Million Pharmacy Forward AI Bet Means For Shareholders - Yahoo Finance
The Cigna Group focuses on health services growth as investors watch its stock - ad-hoc-news.de
Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward - Yahoo Finance Singapore
Goldman Sachs Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $340 - 富途牛牛
New Cigna CEO’s patient-first focus to face Wall Street test - Crain's New York
CICigna Group Volatility & Greeks - Finviz
Top Cigna Group (CI) Competitors 2026 - MarketBeat
Cigna's Evernorth division announces $100M specialty drug AI program - BenefitsPRO
Evernorth Invests $100M for AI Specialty Pharmacy Program - MedCity News
Evernorth Launches AI-Driven Specialty Care Initiative Backed by $100M Investment - citybiz
Cigna Group outlines growth strategy as health benefits demand evolves - AD HOC NEWS
Cigna (CI) Unveils $100M AI-Driven Specialty Care Program to Enh - GuruFocus
Cigna Group Azioni (CI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cigna Group Azioni (CI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kates Jamie G | Chief Accounting Officer |
Jun 12 '26 |
Sale |
298.61 |
899 |
268,452 |
2,368 |
0.99%
1.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):